With healthcare demand rapidly increasing in Asia Pacific and worldwide, the entire healthcare sector is sure to undergo a dramatic revolution. J&J Medical’s Chairman for Asia Pacific discusses his priorities for the company, and for the wider life science industry in his capacity as Chairman of APACMed.
You have served as the chairman of APACMed since it’s foundation last year – why was such a regional level association needed, and what was your vision for how it could create value for patients and industry stakeholders?
"The economic dimension also can contribute to innovation. In the life science industry there is an innovative “value segment” which is present all over the world, from Germany and the US to China or the Philippines; if you are able to demonstrate that you can deliver good clinical outcomes most efficiently then any healthcare system in the world will be interested."
